Clinical Trials Sponsored by Leiner Health Products

Total 363 results

National Institute on Aging (NIA)
Leiner Health Products

Completed

BVAIT: B-Vitamin Atherosclerosis Intervention Trial

Atherosclerosis

United States
United Health Products, Inc.

Completed

Efficacy and Safety of HemoStyp as an Adjunct for Management of Secondary Hemostasis in the Operative Setting

Bleeding | Hemostasis

United States
NOxy Health Products, LLC

Suspended

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers (NTCDU) (NTCDU)

Diabetic Foot Ulcer

Israel
Gynuity Health Projects

Completed

Feasibility of Medical Abortion by Telemedicine in Mexico

Pregnancy

Mexico
Gynuity Health Projects

Completed

Feasibility of Telemedicine Medical Abortion

Pregnancy

United States
Gynuity Health Projects

Unknown

Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso

Medical; Abortion, Fetus

Burkina Faso
Gynuity Health Projects

Terminated

Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death

Fetal Death

Vietnam, Mexico
Gynuity Health Projects

Completed

Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests

Medical Abortion

United States
Gynuity Health Projects

Completed

Simplified Medical Abortion Screening: A Pilot Demonstration Project

Medical; Abortion, Fetus

Moldova, Republic of, United States, Mexico
Gynuity Health Projects

Completed

Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of SQPT for At-Home Follow-Up

Pregnancy

Bolivia, Ecuador
Gynuity Health Projects

Completed

A Trial Comparing Treatment With the Springfusor Infusion Pump to the IV Magnesium Sulfate Regimen

Preeclampsia

Egypt
Gynuity Health Projects

Completed

Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine

Other Abortion

Ukraine
Gynuity Health Projects

Completed

Chart Review Study of Medical Abortion

Abortion, Medical

United States
Gynuity Health Projects

Completed

Study of Immediate Start of Progestin Contraceptives in Medical Abortion (Quickstart)

Contraception

United States, Mexico
Gynuity Health Projects

Completed

Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in Kazakhstan

Complete Abortion

Kazakhstan
Gynuity Health Projects

Completed

Acceptability and Feasibility of a Simplified Medical Abortion Regimen in Georgia

Abortion, First Trimester

Georgia
Gynuity Health Projects

Completed

Exploring the Role of At-home Semi-quantitative Pregnancy Tests for Follow-up to Menstrual Regulation Service

Menstrual Regulation

Pakistan
Gynuity Health Projects

Completed

Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol

Abortion, First Trimester

Armenia, Azerbaijan, Mexico, Puerto Rico
Gynuity Health Projects

Completed

Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test in an Assisted Fertility Setting

Embryo Transfer

Vietnam
Gynuity Health Projects

Completed

Side Effects and Adherence Associated With Doxycycline Use Following Medical Abortion

Abortion

United States
Gynuity Health Projects

Completed

Reducing the Need for In-Clinic Follow-Up for Medical Abortion in Moldova and Uzbekistan

Medical Abortion, Fetus

Moldova, Republic of, Uzbekistan
Gynuity Health Projects

Completed

Comparing Two Regimens for Medical Abortion: Mifepristone + Misoprostol Versus Misoprostol Alone

Complete Abortion

Vietnam, Tunisia
Gynuity Health Projects

Completed

The Acceptability and Feasibility of an Alternative to Routine Follow-up Visit After Medical Abortion in Vietnam

Medical Abortion

Vietnam
Gynuity Health Projects

Completed

Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical Treatment

Incomplete Abortion

Ecuador, Venezuela
Gynuity Health Projects

Completed

A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP

Abortion, Induced

United States
Gynuity Health Projects

Completed

Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation

Pregnancy

United States
Gynuity Health Projects

Completed

Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine

Pregnancy

United States
Gynuity Health Projects

Terminated

Non-surgical Alternatives to Treatment of Failed Medical Abortion

Abortion Failure

United States
Gynuity Health Projects

Terminated

Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial

Pregnancy | Missed Abortion

Argentina, Gabon, Mexico, Pakistan
Gynuity Health Projects

Completed

Simplifying First Trimester Medical Abortion Follow-up

Medical Abortion

Armenia, Georgia, Kazakhstan
Gynuity Health Projects

Completed

Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation (XXGA)

Medical Abortion

United States, Vietnam, Georgia, Azerbaijan, Mexico
Gynuity Health Projects

Terminated

Simplified Medical Abortion Follow-Up

Abortion | Pregnancy Tests

United States
Gynuity Health Projects

Completed

Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh

Menstrual Regulation

Bangladesh
Gynuity Health Projects

Completed

Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion

Termination of Pregnancy

United States
Gynuity Health Projects

Completed

Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))

Abortion, Induced

Moldova, Republic of, Tunisia
Gynuity Health Projects

Completed

Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial

Abortion, Induced

Vietnam
Gynuity Health Projects

Completed

Vaginal and Rectal Clostridial Carriage Among Women of Reproductive Age in the United States

Clostridium Sordellii | Clostridium Perfringens

United States
Gynuity Health Projects

Completed

400mcg Sublingual Misoprostol as First Line Treatment

Incomplete Abortion

Senegal
Gynuity Health Projects

Completed

Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion

Termination of Pregnancy

United States, Moldova, Republic of, Nepal
Gynuity Health Projects

Completed

Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion

Incomplete Abortion

Egypt, Burkina Faso, Mauritania, Niger, Senegal
Gynuity Health Projects

Completed

Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria

Incomplete Abortion

Nigeria
Gynuity Health Projects

Not yet recruiting

Evaluation of Telemedicine Medical Abortion Service in Ecuador

Pregnancy

Ecuador
Gynuity Health Projects

Recruiting

Assessing Medical Menstrual Regulation in the United States

Menstrual Regulation

United States
Gynuity Health Projects

Terminated

Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia

Second Trimester Abortion

Colombia
Gynuity Health Projects

Completed

Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey

Preeclampsia

Mexico
Gynuity Health Projects

Completed

Acceptability and Feasibility of Medical Abortion in Singapore

Medical Abortion

Singapore
Gynuity Health Projects

Completed

Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan

Abortion in Second Trimester

Uzbekistan
Gynuity Health Projects

Completed

Semiquantitative Urine Pregnancy Test Results At ≥9 Weeks of Gestation

Pregnancy
Gynuity Health Projects

Completed

Acceptability and Feasibility of a Demedicalized Medical Abortion Regimen in the Caucasus

Abortion, First Trimester

Armenia, Azerbaijan
Gynuity Health Projects

Completed

Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia

Abortion in Second Trimester

Armenia

3

Subscribe